In contrast, HER2-overexpressing tumor models have been used only infrequently and, in agreement with human epidemiological observations, have not demonstrated an increased risk of primary tumors in the setting of obesity [35]. This evidence concerns the gene ERBB2 and obesity due to melanocortin 4 receptor deficiency.